Objectives: To review all prospective cohort studies examining the relationship between ®sh intake and coronary heart disease mortality, and to assess the strength and consistency of their ®ndings. Design: Systematic review of studies based on individual records of ®sh or n-3 polyunsaturated fatty acid consumption and coronary heart disease death. Studies were given scienti®c quality scores and divided into categories of high, intermediate, or insuf®cient quality. Main outcome measure: Coronary heart disease mortality. Results: Eleven studies were identi®ed. The cohorts counted a total of 116 764 individuals. Of four studies judged to be of high quality, the two largest (n 44 895 and 20 051) were performed in populations at low risk of coronary heart disease. They found no protective effect of ®sh consumption. The other two high-quality studies were relatively small (n 852 and 1822) and included individuals at higher risk. They both found an inverse relationship between ®sh consumption and coronary heart disease death, suggesting that 40 ± 60 g ®sh per day is optimal and associated with a risk reduction of 40 ± 60%. Results of four studies of intermediate quality support that ®sh consumption is inversely associated with coronary heart disease mortality in high-risk populations only. Three studies were judged to be of insuf®cient quality to be used for drawing conclusions. Conclusions: Fish consumption is not associated with reduced coronary heart disease mortality in low-risk populations. However, ®sh consumption at 40 ± 60 g daily is associated with markedly reduced coronary heart disease mortality in high-risk populations. The underlying biochemical mechanism is not known and causal inference premature.
Introduction
Cross-sectional studies among Inuits and Danes, and different Japanese populations suggested that ®sh consumption was protective against coronary heart disease (CHD) (Bang et al, 1980; Hirai et al, 1989) . Later cross-sectional ®ndings were less reassuring, however, and recent casecontrol studies reached con¯icting conclusions (Simonsen et al, 1987; Bjerregaard, 1996; Siscovick et al, 1995; Guallar et al, 1995) . Biochemical research revealed that the very long-chained n-3 polyunsaturated fatty acids (n-3 VLCPUFA), abundantly present in ®sh fat, are potent modulators of human metabolism. Among numerous metabolic effects, n-3 VLCPUFA lower fasting and postprandial plasma concentrations of triglyceride-rich lipoproteins and their remnants, and they modify the eicosanoid pro®le and cardiac excitability in a way that might lead to a reduced risk of CHD (Harris, 1989; Dyerberg, 1981; Schacky et al, 1985; Nordùy et al, 1994; McLennan et al, 1993; Kang & Leaf, 1994) . Potentially athero-and thrombogenic effects have also been reported. These include delayed low density lipoprotein (LDL) clearance, increased LDL oxidisability, and ®brinolytic inhibition (Schectman et al, 1996; Hau et al, 1996; Emeis et al, 1989; Marckmann et al, 1991; Schmidt, 1997) . The health implication of an increased n-3 VLCPUFA intake is therefore not unequivocal. The diverging results of trials in which animals were fed n-3 VLCPUFA further underscore this uncertainty (Weiner et al, 1986; Davis et al, 1987; Fincham et al, 1991; Barbeau et al, 1997) . Accordingly, it is still a controversial issue whether ®sh protects against CHD. In this present study we made an overall assessment of the evidence derived from prospective cohort studies relating ®sh consumption to CHD mortality.
Methods
We restricted our review to prospective cohort studies based on individual recordings of ®sh or n-3 VLCPUFA consumption, and CHD death. We searched for studies in MEDLINE (Medline 1966 and on; search date: January 9, 1998; indexing terms: ®sh, coronary heart disease, journal article; total number of hits: 324), in reference lists of retrieved articles, and using informal sources. Our search identi®ed eleven studies. Nine were published as full-length original papers (Kromhout et al, 1985; Dolecek & Grandits, 1991; Ascherio et al, 1995; Salonen et al, 1995a; Kromhout et al, 1995; Rodriguez et al, 1996; Daviglus et al, 1997; Mann et al, 1997; Albert et al, 1998) . One study was reported in two separate original papers after followup periods of 4 y (Morris et al, 1995) and 11 y (Albert et al, 1998) . They reached similar conclusions. We selected the report of Albert et al for our review because of its longer followup period and higher statistical power. One study was presented in a letter (Vollset et al, 1985) , and one as a short report (Norell et al, 1986) .
Each study was scored for its scienti®c quality on a scale from 0 ± 6 points. Studies scoring 5 ± 6 points were considered of high quality, those scoring 3 ± 4 points of intermediate, and those scoring 2 points or less of insuf®-cient quality. Points were scored according to dietary assessment method (3 points for cross-check dietary history, 2 for semiquantitative food-frequency questionnaire (FFQ), 1 for non-quantitative FFQ, four-day food records, and repeated 24 h recalls, and 0 for unpresented details), CHD death ascertainment (1 point if based on individual medical records, 0 if based on death certi®cates), number of CHD deaths (1 point if 100 deaths, 0 if 100), and statistical presentation (1 point if multivariate analyses were included, 0 if lacking). All studies ful®lled our high-quality criteria for study duration (more than 5 y), and completeness of follow-up (more than 95% of all individuals followed up).
Graphs showing the relation between ®sh intake and CHD death based on actual ®gures presented in original papers judged of high quality were prepared. If ®sh intake was presented as a range, for example, 15 ± 30 g ®sh daily, we assigned the mean of the range for that intake category. For those categories of intake in which intakes below or above a certain level were presented, for example, more than 45 g daily, mean intakes were estimated by us.
Results
The sample size and the length of follow-up varied grossly between studies; from 272 ± 44 895 individuals and from 5 ± 30 y (Table 1) . Only three studies included females.
Study quality
Four studies were judged of high scienti®c quality (scienti®c score: 5 ± 6 points), but none scored the maximum of 6 points ( Table 2) . Another four studies were judged of intermediate quality (3 ± 4 points). Their lower scoring was caused either by their use of less valid dietary assessment methods, small numbers of CHD deaths, or less rigid ascertainment of CHD deaths. Finally, three studies were judged to have insuf®cient quality (2 points) to be included in the overall assessment of the relation between ®sh consumption and CHD death. Dietary assessment methods were poor or poorly described in these studies. Also, they did not validate the CHD death reports individually, only counted small numbers of CHD deaths, or lacked important statistical analyses.
Study outcomes
The observed association between ®sh intake and relative risk of CHD death after adjustment for multiple confounders in the four studies of high quality is presented in Figure 1 .
Relative risks were not signi®cantly different from 1.0 for most intake categories due to wide con®dence intervals. An inverse and graded relationship between ®sh intake and CHD death was observed by Kromhout et al (1985) and Daviglus et al (1997) , but it was absent in the other two studies of much larger cohorts (P-values for trend: 0.19 and 0.49) (Ascherio et al, 1995; Albert et al, 1998) . However, Ascherio et al (1995) observed that eating any amount of ®sh as compared with eating no ®sh was associated with an insigni®cantly lowered risk of CHD death (RR 0.74, 95% Norell, 1985 1 Yes a Similar conclusion was reached after the ®rst four years of follow-up (Morris et al, 1995) .
Fish consumption and coronary heart disease mortality P Marckmann and M Grùnbñk CI: 0.44 ± 1.23). Paradoxically, the risk of any CHD event was slightly increased among individuals with the highest ®sh intake as compared with those eating the least ®sh in the same study (RR 1.14, 95% CI: 0.86 ± 1.51). The papers by Ascherio et al (1995) and Albert et al (1998) included information about the incidence of myocardial infarction. It was unrelated to ®sh consumption in both studies. Estimated absolute CHD death rates in the four highquality studies are presented in Figure 2 .
The conclusions reached in the four studies of intermediate quality also diverged (Table 2) . Dolecek & Grandits (1991) reported an inverse relationship between quintiles of dietary n-3 VLCPUFA intake and CHD mortality (the amount of ®sh consumed was not reported). In a small Dutch cohort (n 272), Kromhout et al (1995) observed that ®sh consumers with an average ®sh intake of 24 gad had an adjusted relative risk of CHD death of 0.51 (95% CI: 0.29 ± 0.89) as compared with those not eating ®sh. In contrast, Rodriguez et al (1996) and Mann et al (1997) were unable to demonstrate any association between ®sh consumption and CHD death in their studies in which participants were divided into two or three categories of ®sh consumption, respectively.
The three studies of insuf®cient quality concluded that ®sh consumption was associated with an increased, an unaltered, or a lowered risk of CHD death (Table 2) .
Discussion
Fish consumption is closely linked to a series of other dietary variables as well as non-dietary lifestyle factors that may have an impact on CHD mortality (Kromhout et al, 1985; Ascherio et al, 1995; Morris et al, 1995; Albert et al, 1998) . Although most of the reviewed studies made statistical adjustments for known potential confounders, residual confounding can never be ruled out. Figure 1 Multivariate adjusted relative risk of coronary heart disease (CHD) death and 95% con®dence intervals as a function of ®sh consumption in four high-quality studies. Two found ®sh consumption to be uncorrelated with CHD death (Ascherio et al (1995) ; Albert et al (1998) ), and two found an inverse association (Kromhout et al, (1985) ; Daviglus et al (1997) ). P-values for the presence of a trend across intake categories is also presented. Figure 2 The association between ®sh consumption and absolute coronary heart disease (CHD) death rates (deathsa1000 y) in four high-quality studies. Absolute death rates were calculated as published relative risk of each intake category times average CHD death rate in the total population (cf. Table 1 ). This gives an incorrect, but reasonable crude estimate.
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Studies showing no protective effect of ®sh consumption Four important studies (two of high and two of intermediate quality) found no signi®cant association between ®sh consumption and CHD mortality (Ascherio et al, 1995; Rodriguez et al, 1996; Mann et al, 1997; Albert et al, 1998) . All four studies were large, their cohorts counting from 7513 ± 44 985 individuals. In three of the studies (Ascherio et al, 1995; Rodriguez et al, 1996; Albert et al, 1998) , the number of CHD deaths and the variability in ®sh intake among participants was suf®ciently large to detect an inverse association between ®sh consumption and CHD mortality similar to that reported by Kromhout et al (1985) with considerable statistical power. In line with these negative studies, a recent cross-cultural study concluded that ®sh consumption did not contribute signi®cantly to the differences in CHD mortality between the sixteen cohorts of the Seven Countries Study (Kromhout et al, 1996) . In that study crude data analysis showed an inverse association between ®sh consumption and CHD death, but it disappeared when adjustments were made for the intake of saturated fat, and¯avonoids and smoking. It is of note that the¯avonoid intake was not adjusted for in any of the studies included in the present review.
One relatively small study from Finland (n 1833) concluded that ®sh consumption may be associated with increased CHD mortality (Salonen et al, 1995a) . The dietary assessment method was not optimal in that study. However, corresponding results were obtained when a biomarker for ®sh consumption (serum concentrations of fatty acids) was used in the statistical analyses which strongly supports the ®nding (Salonen et al, 1995b) . The authors underlined that a high intake of mercury from polluted ®sh promoting lipid peroxidation could be the more likely explanation of their unexpected observation.
Studies showing a protective effect of ®sh or n-3 VLCPUFA Four studies (two of high and two of intermediate quality) showed a protective effect of ®sh or n-3 VLCPUFA intake on CHD death (Kromhout et al, 1985; Dolecek & Grandits, 1991; Kromhout et al, 1995; Daviglus et al, 1997) . Three of them were based on relatively small cohorts (n 272 ± 1822). The two smallest cohorts were Dutch and comprised randomly selected individuals born in the beginning of the century (Kromhout et al, 1985 (Kromhout et al, , 1995 . The larger study by Dolecek & Grandits (1991) was based on observations of the control group of the MRFIT study (n 6258 males). Participants of this control group were all diagnosed as having an increased risk of CHD at study entry, but had been randomised to usual care. Fish consumption data were not presented, but a protective effect of n-3 VLCPUFA was found. A particular problem relating to this study was that the n-3 VLCPUFA intake was calculated as the average of ®ve 24 h recalls obtained at baseline and after 1, 2, 3, and 6 y of follow-up. This approach entails a considerable risk of biased estimates because individuals classi®ed as having a high average n-3 VLCPUFA intake are likely to be the ones that improved their overall life-style during follow-up. The statistical analyses did not take that problem into account.
The most recent report showing that ®sh may protect against CHD death was based on 30 y follow-up data on 1822 males from the Chicago area (Daviglus et al, 1997; Shekelle et al, 1981 Shekelle et al, , 1985 . The protective effect was not apparent in the crude analysis, but appeared in the multivariate analysis as a signi®cant trend (P 0.04). It was primarily explained by a strong inverse association between ®sh intake and nonsudden cardiac death among those 47 y or older at study entrance (Daviglus et al, 1997) . This ®nding contrasts remarkably with observations reported by Albert et al (1998) , who found ®sh to protect against sudden, but not against nonsudden cardiac death. Furthermore, total CHD mortality was unrelated to ®sh consumption in Albert's study.
The dose-response data presented in the two highquality studies with positive outcome indicate that the protective effect is graded until a possible optimum of around 40 ± 60 g ®sh equivalent with an estimated 0.6 ± 0.9 g n-3 VLCPUFA per day (see Figures 1 and 2 ). As compared with not eating ®sh, a relative risk of 0.4 ± 0.6 of dying from CHD might be achieved at this optimal intake. Corresponding results were reported from a case-control study (Siscovick et al, 1995) . In that study, an average intake of 13.65 g n-3 VLCPUFA per month (0.45 gad) was associated with a relative risk of primary cardiac arrest of 0.4 (95% CI: 0.2 ± 0.7).
Combining the evidence
The two large high-quality studies that were both negative included American health professionals with healthy lifestyles (Ascherio et al, 1995; Albert et al, 1998) . Among these individuals there were few current smokers (8 ± 13%), they had low saturated fat intakes of less than 10% of total energy intake, desirable total cholesterol concentrations around 5 mmolaL (only presented in Ascherio's paper), and low CHD death rates (1.0 and 1.4 CHD deaths for every 1000 person years of follow-up (Table 1) ). In contrast, the two high-quality studies showing a protective effect of ®sh comprised participants at a much higher absolute risk of CHD and with unhealthy lifestyles. The CHD death rate was 4.6 for every 1000 person years in the study by Kromhout et al (1985) , and 7.9 in the Western Electric Study (Daviglus et al, 1997) . Furthermore, participants had average saturated fat intakes of 16 ± 18% of energy. In the latter study average cholesterol concentrations were close to 6 mmolaL, and almost 60% were smokers.
A similar pattern of differences between studies showing or not showing an association between ®sh and CHD death applies to the four intermediate-quality studies. The two negative studies investigated cohorts with relatively low rates of CHD mortality for age (Rodriguez et al, 1996; Mann et al, 1997) . In contrast, both studies showing a protective effect of ®sh was conducted in high-risk cohorts (Dolecek & Grandits, 1991; Kromhout et al, 1995) . In the Dutch study, participants were characterised by 70% of the men and 20% of the women being smokers, by average saturated fat intakes of 17 ± 18% of energy, average cholesterol concentrations above 6 mmolaL, and a CHD death rate of 12.5 for every 1000 person years (Kromhout et al, 1995) . Participants of the study by Dolecek & Grandits (1991) were high-risk individuals by de®nition (inclusion criteria for MRFIT).
Conclusions
Our overall conclusion is that individuals at low risk of CHD and with healthy life-styles do not gain any additional protection against CHD from eating ®sh. On the other hand, high-risk individuals appear to bene®t in a dose-dependent manner from increasing their ®sh consumption up to an optimum of 40 ± 60 g. At the optimal ®sh intake, risk of Fish consumption and coronary heart disease mortality P Marckmann and M Grùnbñk CHD death may be only around half the risk of individuals not eating ®sh at all. Results of a large intervention study of post-infarct patients support that increased ®sh consumption lowers CHD mortality in high-risk individuals (Burr et al, 1989) . In this study, increasing ®sh intake from an estimated 10 ± 20 g daily to 30 ± 60 g daily (200 ± 400 g weekly) resulted in a 30% reduction in CHD mortality. The question remains whether the apparent protection in high-risk individuals is directly caused by the ®sh itself.
There is yet no de®nitive answer to that question. Dietary intervention studies demonstrated that the consumption of up to 0.9 g n-3 VLCPUFA daily Ð corresponding to a daily intake of 40 ± 60 g ®sh of mixed type (lean, intermediate, and fatty) Ð has no signi®cant impact on classical CHD risk factors such as low density lipoprotein cholesterol and ®brinogen, or most other putative mediators of atherothrombogenesis (Lervang et al, 1993; Schmidt et al, 1996; Marckmann et al, 1997) . The postprandial triglyceride pro®le is one obvious exception. At a daily intake of 0.9 g n-3 VLCPUFA, a marked depression of postprandial triglyceride concentrations is seen (Marckmann et al, 1997) . Also, n-3 VLCPUFA accumulate in tissues even at low intakes which might, theoretically, have an impact on membrane function and cardiac excitability. Taking the absent in¯uence on stronger determinants of CHD risk into account, it nevertheless seems unlikely that n-3 VLCPUFA effects could solely explain the very marked cardioprotective effect of moderate ®sh consumption. The same opinion was expressed earlier by Kromhout et al (1985) . Supporting this viewpoint, Ascherio et al (1995) and Albert et al (1998) found no protective effect of n-3 VLCPUFA in speci®c analyses of their large data materials. The link between ®sh consumption and CHD mortality in high-risk populations therefore might be due to other ®sh components than n-3 VLCPUFA. Alternatively, the link might be explained by undetected dietary or non-dietary confounders. That possibility is supported when the ®sh-CHD link is compared with the evidence linking alcohol and CHD. The association is much more consistent in the latter case (Maclure, 1993) . Additional prospective cohort studies and in particular intervention studies are obviously needed to further clarify the role of ®sh consumption in the prevention of CHD death. Future studies should focus on high-risk individuals and preferably include a test of the underlying biochemical hypotheses. Based on current evidence, we believe that it is justi®ed to recommend increased ®sh consumption up to an optimum of 40 ± 60 gad for fatal CHD prevention in highrisk populations. There is not suf®cient evidence to assume that corresponding amounts of n-3 VLCPUFA taken as a dietary supplement can be similarly protective.
